Patent · US Active

Substituted nucleosides, nucleotides and analogs thereof

US9598457B2 · kind B2 · utility

20Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 19, 2013
Grant dateMar 21, 2017
Priority date
Expiry dateDec 19, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.